KabuDo

NASDAQ: MCHP · Semiconductors

Microchip Technology

Microchip Technology, based in Chandler, Arizona, makes embedded control semiconductors — microcontrollers, microprocessors, analog, FPGA, connectivity, data center and memory products — sold as “Total System Solutions” of hardware, software and services to a very broad customer base, largely through distributors. Fiscal 2026 net sales (year ended March 31, 2026) rose 7% to $4,713 million: mixed-signal microcontrollers $2,355 million (50%), analog $1,329 million (28%) and other $1,029 million. That was a partial recovery from a severe inventory correction: sales had fallen from $8,439 million in fiscal 2023 to $4,402 million in fiscal 2025, when Microchip broke even, launched a business recovery plan, cut headcount and closed its Tempe Fab 2. Fiscal 2026 net income was $230 million, though EPS was only $0.22 after dividends on 7.50% mandatory convertible preferred stock. Arrow Electronics, its largest distributor, accounted for 12% of sales.

Last updated

Analysis last edited: November 6, 2026 · Financial data fetched: October 29, 2026 13:24 (SEC EDGAR) · Source 10-K filed: May 21, 2026

Built on10-K FY2026 · filed 2026-05-2110-Q (quarter ended 2026-09-30) · filed 2026-11-05Proxy statement (2026)

Next update expectedAfter FY2027’s 10-K is filed (roughly 60–90 days after fiscal year end (sooner for larger filers)), financials and analysis will be refreshed.

01

At a glanceFrom SEC data

Eight headline measures, each placed among the companies covered on this site.

Revenue growth
-2.8%

Higher than 3% of 372 non-financial companies

Average yearly growth over the years shown

Operating margin
10.4%

Higher than 27% of 311 non-financial companies

Latest fiscal year (FY2026)

ROIC minus WACC
-9.6 pts

Higher than 4% of 311 non-financial companies

Return on capital above (or below) its estimated cost

Net debt ÷ EBITDA
4.5x

Higher than 84% of 304 non-financial companies

Below 0 means more cash than debt

Cash conversion
4.18x

Higher than 93% of 349 non-financial companies

Operating cash flow ÷ net income

Dividend raises
5 of 5

Years the dividend per share rose, of the last 5

P/E today
50.7x

Latest close 2026-11-04; trailing 12 months to 2026-09-30

Beta
1.69

Above 1 = moves more than the market

Each marker shows where this company sits among the non-financial companies covered on this site, not all listed companies (left = lowest, right = highest). A high position is not automatically good — for net debt ÷ EBITDA, higher means more debt. Details and formulas are in the sections below and in How to read this.

02

Valuation todayFrom SEC data

Price-based measures at the latest close, next to the same measures at the last fiscal year-end.

Share price$78.36close on 2026-11-04

Market cap$42.48B

P/E today
50.7x

At FY2026 year-end: 293.7x

Earnings: trailing 12 months to 2026-09-30

P/B today
6.6x

At FY2026 year-end: 5.4x

Book value at FY2026 year-end

EV/EBITDA today
40.5x

At FY2026 year-end: 34.2x

EBITDA for FY2026

FCF yield today
2.1%

At FY2026 year-end: 2.5%

Free cash flow for FY2026

Dividend yield today
1.2%

Dividends per share for FY2026

“Today” uses the latest closing price (2026-11-04, Yahoo Finance daily closing prices) and shares outstanding at the last fiscal year-end. The rest of this page — including the financial table and ROIC vs. WACC — uses fiscal year-end prices. These are reference figures, not a judgment of whether the stock is cheap or expensive.

03

What changed since last earningsFrom SEC data

The latest reported quarter against the same quarter a year earlier, the balance sheet against the previous quarter-end, and what management said in its latest earnings release.

Quarter ended Sep 30, 2026.

  • Revenue↑ +42.2%$1.14B → $1.62B (vs. a year earlier)
  • Operating margin↑ +20.9 pts7.8% → 28.6% (vs. a year earlier)
  • Net income↑ +862.6%$42M → $401M (vs. a year earlier)
  • Diluted EPS↑ +2166.7%$0.03 → $0.68 (vs. a year earlier)
  • Cash↑ +67.8%$272M → $457M (vs. previous quarter-end)
  • Long-term debt↑ +2.9%$5.36B → $5.52B (vs. previous quarter-end)

Source: Form 10-Q ↗ (SEC XBRL). Long-term debt is the tagged long-term debt figure and leaves out short-term borrowings.

From the earnings release of Aug 6, 2026.

Key changes

  • Net sales $1.485B, up 38.0%. Source sentence
    Net sales of $1.485 billion, increased 38.0% from the year-ago quarter and up 13.2% sequentially.

Written by AI. A line appears only if its figures and direction match the quoted sentence, which an automatic check confirms. Companies' outlooks are their own and may not be met. Read the release ↗

04

Company profileFrom SEC dataShow

Legal name
MICROCHIP TECHNOLOGY INC
Headquarters
CHANDLER, AZ
Incorporated in
Delaware
Fiscal year end
03/31
Exchange & ticker
NASDAQ: MCHP
Industry
Semiconductors
CIK
827054

Workforce (as of FY2026 year-end)

  • Employees

    17,900

Source: Form 10-K (FY2026) cover page and business description

05

Earnings calendarFrom SEC dataShow

When the company reports each quarter: the quarter-end date, the day results were released, and when the 10-Q or 10-K was filed.

Next report

Q3 FY2027

Quarter end: December 2026. In past years, Q3 results were released 32–37 days after quarter end (Feb 5, 2026; Feb 6, 2025; Feb 1, 2024). No date has been announced in the sources this site uses.

Reporting pattern

  • Fiscal year ends around March 31.
  • Reports four times a year: three quarterly reports (10-Q) and an annual report (10-K) for Q4.
  • Earnings releases came 32–38 days after quarter end over the last 12 quarters.
QuarterQuarter endedEarnings release (8-K)Report filed (10-Q / 10-K)
Q2 FY2027Sep 30, 2026Nov 5, 2026 (+36 days)Nov 5, 2026 10-Q (+36 days)
Q1 FY2027Jun 30, 2026Aug 6, 2026 (+37 days)Aug 6, 2026 10-Q (+37 days)
Q4 FY2026Mar 31, 2026May 7, 2026 (+37 days)May 21, 2026 10-K (+51 days)
Q3 FY2026Dec 31, 2025Feb 5, 2026 (+36 days)Feb 5, 2026 10-Q (+36 days)
Q2 FY2026Sep 30, 2025Nov 6, 2025 (+37 days)Nov 6, 2025 10-Q (+37 days)
Q1 FY2026Jun 30, 2025Aug 7, 2025 (+38 days)Aug 7, 2025 10-Q (+38 days)
Q4 FY2025Mar 31, 2025May 8, 2025 (+38 days)May 23, 2025 10-K (+53 days)
Q3 FY2025Dec 31, 2024Feb 6, 2025 (+37 days)Feb 6, 2025 10-Q (+37 days)
Q2 FY2025Sep 30, 2024Nov 5, 2024 (+36 days)Nov 5, 2024 10-Q (+36 days)
Q1 FY2025Jun 30, 2024Aug 1, 2024 (+32 days)Aug 1, 2024 10-Q (+32 days)
Q4 FY2024Mar 31, 2024May 6, 2024 (+36 days)May 23, 2024 10-K (+53 days)
Q3 FY2024Dec 31, 2023Feb 1, 2024 (+32 days)Feb 1, 2024 10-Q (+32 days)

Source: SEC EDGAR filing history. Release dates are the dates the earnings release was furnished to the SEC on Form 8-K (Item 2.02), which is normally the day results are announced. For a quarter whose 10-Q or 10-K isn’t filed yet, the date is the latest Item 2.02 8-K since the previous report, which may be a preliminary or other results-related update. Fiscal years are labeled by the calendar year in which they end.

06

Flagship products & servicesSite analysis

  • Mixed-signal microcontrollers

    Microcontrollers and microprocessors

    8- through 32-bit microcontrollers and 64-bit microprocessors.

  • Analog

    Analog and interface

    Power management, mixed-signal, linear, interface and timing products.

  • Other

    FPGA, memory and licensing

    FPGAs, memory products and technology licensing.

From the Form 10-K, FY2026, year ended 2026-03-31.

U.S. and worldwide share of flagship products/services

The 10-K gives no market-share figures.

Reviewed: Form 10-K (FY2026, year ended 2026-03-31) · Form 10-Q (quarter ended 2026-06-30)

07

Recent strategic focusSite analysis

Recent developments.

  1. Business recovery plan

    March 2025 restructuring to cut costs, resize manufacturing and reduce headcount.

    Source: Form 10-K (FY2026, year ended 2026-03-31)

  2. Fab 2 closure

    Closed Tempe Fab 2 by May 2025, moving processes to Fab 4 and Fab 5.

    Source: Form 10-K (FY2026, year ended 2026-03-31)

  3. Preferred stock

    Issued 7.50% Series A mandatory convertible preferred stock (traded as MCHPP).

    Source: Form 10-K (FY2026, year ended 2026-03-31)

Capex ÷ D&A (FY2026)

0.13x

Below depreciation — investment is being pared back

formulacapital expenditures ÷ depreciation & amortization

e.g.$91M ÷ $689M = 0.13x

termsCapital expenditures (capex) · Depreciation & amortization (D&A)

R&D-to-revenue ratio (FY2026)

23.0%

formularesearch & development expense ÷ revenue × 100

e.g.$1,086M ÷ $4,713M × 100 = 23.0%

termsResearch & development (R&D) · Revenue (net sales)

Where the money goes, over time

Unit: $M. Capex went from $93M in FY2021 to $91M in FY2026

  • Capex
  • R&D

formulacapital expenditures ÷ depreciation & amortization

termsCapital expenditures (capex) · Depreciation & amortization (D&A)

Source: each period's Form 10-K (SEC EDGAR). Latest: filed 2026-05-21

08

Key figures at a glanceFrom SEC data

FY2021–FY2026, 6 years.

Revenue (FY2026)

$4.71B

As reported in the 10-K

Revenue CAGR (5 years)

-2.8%▼caution

formula(last-period revenue ÷ first-period revenue) ^ (1 ÷ years) − 1

e.g.($4,713M ÷ $5,438M) ^ (1÷5) − 1 = -2.8%

termsCAGR · ^ (exponent) · Revenue (net sales)

Operating margin (FY2026)

10.4%▼caution

-8.0pt vs. 5 years ago

formulaoperating income ÷ revenue × 100

e.g.$490M ÷ $4,713M × 100 = 10.4%

termsOperating income · Revenue (net sales)

ROE (FY2026)

3.4%▼caution

6-year average: 16.3%

As reported in the 10-K

P/B (FY2026 end)

5.44x

formulafiscal year-end closing price ÷ book value per share

e.g.$64.61 ÷ $11.87 = 5.44x

termsP/B · BVPS

Period-end (fiscal year-end) value, not today's P/B

EV/EBITDA (FY2026 end)

34.2x

formula(market cap + interest-bearing debt − cash and equivalents) ÷ (operating income + depreciation & amortization)

e.g.($35,024M + $5,496M − $240M) ÷ ($490M + $689M) = 34.2x

termsEV/EBITDA · Market capitalization · Interest-bearing debt · EBITDA · Depreciation & amortization (D&A)

Period-end (fiscal year-end) value, not today's multiple

  • ▼

    Revenue grew -2.8% a year over 5 years (a shrinking trend)

    From $5.44B in FY2021 to $4.71B in FY2026. The annualized rate (CAGR) makes it possible to compare growth pace across companies of different sizes.

  • ▼

    Operating margin declined: 18.4% → 10.4%

    How much operating profit is left per $100 of revenue. It moved -8.0 points over 5 years — pricing power, cost control, and product mix all show up here.

  • ―

    Equity ratio is 44.8% (a middling level)

    The share of total assets funded by equity rather than debt. 50%+ is often read as low bankruptcy risk, though the right level varies by industry (real estate and leasing run lower, for instance).

  • ▲

    Free cash flow was positive in 6 of 6 years

    Operating cash flow minus capital expenditures: the cash left over after funding the business’s own investment, available for dividends, buybacks, acquisitions, or debt paydown. A negative year can mean heavy investment, or weak core earnings — worth distinguishing.

  • ▲

    ROE averaged 16.3% over 6 years (latest: 3.4%)

    How much profit was generated on shareholders’ equity. Roughly 10%+ is often cited as solid for a U.S. company, though this varies a lot by industry and capital intensity.

09

Business modelSite analysis

Designs and makes microcontrollers, analog and related chips in its own fabs and with foundries, and sells them through distributors and directly to about 101,000 customers across many end markets, supported by development tools.

How money and goods flow at Microchip Technology
  1. 01 what it draws on

    Inputs & resources

    • About 17,900 employees
    • Own wafer fabs (Fab 4, Fab 5) plus outsourced capacity
    • Large portfolio of proprietary products and development tools
  2. 02 what it does

    Activities

    • Mixed-signal microcontrollers and microprocessors
    • Analog
    • Other: FPGA, licensing, memory, connectivity
  3. 03 who it serves

    Customers

    • Distributors (Arrow 12% of FY2026 sales) and direct OEMs across many end markets
  4. 04 how money comes in

    How it earns

    • Mixed-signal microcontrollers $2,355M (FY2026)
    • Analog $1,329M
    • Other $1,029M

How the business makes money

  • Sales by region FY2026: Asia 49.9%, Americas 29.5%, Europe 20.6%.
  • Entered the 64-bit mixed-signal microprocessor market in July 2024.
  • About 101,000 customers; the ten largest direct customers were about 11% of fiscal 2026 revenue.

Government & regulation around the business

Non-market factors from the company’s filings: what governments and regulators fund, buy, set, approve or restrict, and which part of the flow above each one touches.

Microchip spreads wafer production across regions to limit trade and geopolitical disruption.

  • Trade & export rules

    Geographic diversification

    Diversifying wafer production geographically helps prevent disruptions from geopolitical tensions, tariffs or natural disasters.

    Supports and constrainsTouches: Inputs & resources · Activities

    Source: Form 10-K (FY2026)

  • Environmental rules

    Hazardous-substance rules

    Must comply with regulations on use, emissions and disposal of hazardous substances in products and manufacturing.

    Constrains the businessTouches: Activities

    Source: Form 10-K (FY2026)

Revenue by segment (FY2026)

Unit: $M — bar length = revenue, (%) = share of total company revenue

  • Mixed-signal microcontrollers

    2,355.4 (50%)
  • Analog

    1,329 (28%)
  • Other

    1,028.7 (22%)

Source: Form 10-K (FY2026, year ended 2026-03-31) Net sales by product line; total $4,713M.

10

Where it earnsSite analysis

Many U.S.-listed companies earn most of their revenue outside the U.S. — this breaks down revenue by country/region so it's clear where the business actually makes its money.

Largest market (FY2026)

Asia — 50% of revenue

Revenue by country / region (FY2026)

Unit: $M — bar length = revenue, (%) = share of total company revenue

  • Asia

    2,352.9 (50%)
  • Americas

    1,391.3 (30%)
  • Europe

    968.9 (21%)

Source: Form 10-K (FY2026, year ended 2026-03-31) Net sales by region.

11

Contract structureSite analysisShow

Short-term or spot sales carry different earnings quality than long-term or auto-renewing contracts — this shows how the company actually contracts with its customers.

12

Customers & suppliersSite analysis

Who the company sells to and buys from. Companies rarely name either, so named counterparties come only from the company's own filings and press releases; otherwise this lists the concentration figures the 10-K discloses.

Customers

Distributors and OEMs worldwide.

Named by the company

Suppliers

Foundries, assembly and test subcontractors, materials suppliers.

Named by the company

No single material supplier is named.

13

Competitors & peersSite analysis

Competitors the 10-K names, and the peer group the company itself chose in its proxy statement. Nothing here is this site's own pick.

The 10-K says Microchip competes with major domestic and international semiconductor companies and with firms that clone its products, without naming them.

Competitors named in the 10-K

Company names link to this site’s analysis where one exists; “site ↗” opens the company’s own website.

14

Six years of financialsFrom SEC data

Each chart's axis holds a single unit (never mixing dollars, %, and $/share). The table's per-period header links to the filing the numbers came from.

Revenue over time

Unit: $M

Source: each period's Form 10-K (SEC EDGAR). Latest: filed 2026-05-21

Profit over time (operating → net)

Unit: $M

  • Operating income
  • Pretax income
  • Net income

Source: each period's Form 10-K (SEC EDGAR). Latest: filed 2026-05-21

Margins over time

Unit: %

  • Operating margin
  • Net margin

formulaoperating income ÷ revenue × 100

termsOperating income · Revenue (net sales)

formulanet income attributable to the company ÷ revenue × 100

termsNet income (attributable to the company)

Cash flow over time

Unit: $M (below zero = cash went out)

  • Operating CF
  • Investing CF
  • Free CF

formulacash flow from operations − capital expenditures

termsFree cash flow (FCF) · Cash flow from operations (operating CF) · Capital expenditures (capex)

Source: each period's Form 10-K (SEC EDGAR). Latest: filed 2026-05-21

Financial stability & capital efficiency

Unit: %

  • Equity ratio
  • ROE

formulatotal equity ÷ total assets × 100 (as reported in the 10-K)

termsStockholders’ equity · Total assets

formulanet income ÷ average equity (beginning + ending, ÷2) × 100 (as reported in the 10-K)

termsNet income (attributable to the company) · Stockholders’ equity

Earnings per share (EPS) and dividend per share

Unit: $

  • EPS
  • Dividend per share

Source: each period's Form 10-K (SEC EDGAR). Latest: filed 2026-05-21

Line itemFY202110-K on EDGAR ↗FY202210-K on EDGAR ↗FY202310-K on EDGAR ↗FY202410-K on EDGAR ↗FY202510-K on EDGAR ↗FY202610-K on EDGAR ↗
Income statement ($M)
Revenue5,4386,8218,4397,6344,4024,713
Operating income9981,8503,1162,571296490
Pretax income3401,4832,9102,36639274
Net income (attributable)3491,2862,2381,907-0230
Revenue growthcalc(this year’s revenue − last year’s revenue) ÷ last year’s revenue × 100—25.4%23.7%-9.5%-42.3%7.1%
Operating margincalcoperating income ÷ revenue × 10018.4%27.1%36.9%33.7%6.7%10.4%
Net margincalcnet income attributable to the company ÷ revenue × 1006.4%18.8%26.5%25.0%-0.0%4.9%
Balance sheet ($M)
Total assets16,47916,20016,37015,87315,37514,370
Total equity5,3375,8956,5146,6587,0786,432
Interest-bearing debtSum of short- and long-term borrowings, notes/bonds payable8,9047,6876,4406,0005,6305,496
Equity ratio32.4%36.4%39.8%41.9%46.0%44.8%
ROE6.5%22.9%36.1%29.0%-0.0%3.4%
Cash flow ($M)
Operating CF1,9172,8433,6212,893898962
Investing CF-173-478-599-392-288-195
Financing CF-1,864-2,328-3,105-2,415-158-1,298
Free cash flowcalccash flow from operations − capital expenditures1,8242,4733,1352,608772871
Cash and equivalents280317234320772240
Per share & other
EPS ($)0.652.274.023.48-0.010.22
BVPS ($)9.7610.6311.9412.4113.1411.87
Dividend per share ($)0.37as paid 0.75÷20.46as paid 0.91÷20.63as paid 1.26÷20.84as paid 1.68÷20.91as paid 1.82÷20.91as paid 1.82÷2
Payout ratiocalcdividend per share ÷ diluted EPS × 10057.5%20.0%15.7%24.2%—413.6%
P/E (x)119.433.120.825.8—293.7
EV/EBITDA (x)calc(market cap + interest-bearing debt − cash and equivalents) ÷ (operating income + depreciation & amortization)23.716.412.615.629.634.2
P/B (x)calcfiscal year-end closing price ÷ book value per share7.967.077.027.233.685.44

Because of stock splits, all per-share figures are restated onto the most recent period’s share count (the as-filed figure is shown underneath). A payout ratio isn’t computed for a year in which a split occurred mid-year, since the interim and final dividend use different bases. P/B and EV/EBITDA use each period’s period-end (fiscal year-end) figures, not the current share price. Figures without a "calc" tag are as reported in the Form 10-K (the consolidated financial statements and, for older years, earlier 10-Ks), pulled automatically from SEC EDGAR. Where a later filing restated a prior period, the restated figure is used.

Last 8 quarters

Three-month figures from 10-Q filings. Change is versus the same quarter a year earlier. Newest quarter on top.

Quarter endedRevenueOperating incomeNet incomeDiluted EPS
2026-09-30$1.62B+42.2%$465M+422.5%$401M+862.6%$0.68
2026-06-30$1.48B+38.0%$337M+949.2%$230M$0.37
2026-03-31 †$1.31B+35.1%$217M$144M—
2025-12-31$1.19B+15.6%$152M+390.9%$63M$0.06
2025-09-30$1.14B$89M$42M$0.03
2025-06-30$1.08B$32M−$19M$-0.09
2025-03-31 †$971M−$100M−$155M—
2024-12-31$1.03B$31M−$54M$-0.10

† Fourth quarter = the 10-K’s annual figure minus the first three quarters; quarterly EPS isn’t derived this way because share counts change during the year.

15

Is ROIC above WACC?From SEC data

ROIC (the return on money invested in the business) above WACC (the cost of raising that money) means the company is creating value. WACC is an estimate, so its assumptions can be adjusted below.

ROIC (FY2026)

3.2%

formulaoperating income × (1 − tax rate) ÷ invested capital × 100 *invested capital = interest-bearing debt + total equity (average of beginning/ending)

e.g.$490M × (1 − 20%) ÷ $12,319M × 100 = 3.2%

termsOperating income · Effective tax rate · Invested capital · Interest-bearing debt · Total equity

WACC (this site’s estimate)

12.75%

formulacost of equity × equity weight + cost of debt × (1 − tax rate) × debt weight

e.g.Equity weight: $35.02B ÷ ($35.02B + $5.5B) = 86.4%

e.g.Debt weight: $5.5B ÷ ($35.02B + $5.5B) = 13.6%

e.g.WACC: 14.2% × 86.4% + 4.0% × (1 − 20%) × 13.6% = 12.75%

termsCost of equity · Equity weight (E/(D+E)) · Cost of debt · (1 − tax rate) · Debt weight (D/(D+E)) · Market capitalization

ROIC − WACC

-9.6pt▼caution

Falling short of the cost of capital (ROIC > WACC in only 2 of 6 years)

formulaROIC − WACC (positive means the business earns more than its cost of capital)

termsROIC · WACC

How firm is this? With the equity risk premium ±1 point and beta ±0.2, WACC runs 10.5%–15.3% and ROIC − WACC runs −12.2 to −7.3 points. The sign holds across this range. This describes the latest year and does not predict future value creation.

WACC 12.75% is this site’s estimate under the assumptions below (not a figure the company has published)

Risk-free rate
4.95% (10-year Treasury, 2026-11-03)
β
1.69 (price-derived adjusted beta)
Equity risk premium
5.5%
Cost of equity
14.25%
Cost of debt
4.03%
Tax rate
20% (effective rate, FY2024–FY2026)
Capital structure (equity : debt)
86% : 14%
→ Change assumptions and recalculate

ROIC over time, vs. WACC

Unit: % — bars = each period's ROIC, horizontal line = latest WACC. Bars above the line are green, below are red

  • ROIC (above WACC)
  • ROIC (below WACC)
  • WACC 12.75%

formulaoperating income × (1 − tax rate) ÷ invested capital × 100 *invested capital = interest-bearing debt + total equity (average of beginning/ending)

termsOperating income · Effective tax rate · Invested capital · Interest-bearing debt · Total equity

formulacost of equity × equity weight + cost of debt × (1 − tax rate) × debt weight

termsCost of equity · Equity weight (E/(D+E)) · Cost of debt · (1 − tax rate) · Debt weight (D/(D+E)) · Market capitalization

Try different WACC assumptions

β and the equity risk premium are estimates with a real range of plausible values — move the sliders to check whether ROIC > WACC still holds. The risk-free rate starts at the 10-year Treasury yield on 2026-11-03 (U.S. Treasury).

Initial β: 1.69 (price-derived adjusted beta. Raw β 2.03, R² 0.36, 130 weeks)

formula0.67 × β + 0.33 (β = the slope of weekly stock returns regressed on weekly market returns)

e.g.0.67 × 2.030 + 0.33 = 1.690

termsβ (beta)

Period 2024-05-10–2026-11-04, using S&P 500 ETF (SPY) as the market proxy. Source: Yahoo Finance price history.

Cost of equity14.25%

formularisk-free rate + β × equity risk premium

e.g.5.0% + 1.69 × 5.5% = 14.2%

termsCAPM · Risk-free rate · β (beta) · Equity risk premium (market risk premium)

Market value of equity$35.02B

formulafiscal year-end closing price × shares outstanding (= market cap)

termsMarket capitalization · Market value of equity

Interest-bearing debt$5.5B
Cost of debt4.03%

formulainterest expense ÷ interest-bearing debt × 100 (clamped to 0–10%; falls back to the risk-free rate if there’s no debt)

termsInterest-bearing debt · Risk-free rate

Capital structure (equity weight : debt weight)86% : 14%

16

What the price implies (DCF)From SEC data

A company's value can be written as its free cash flow divided by (cost of capital − perpetual growth). Working that backwards from the market's valuation shows how much growth the share price assumed — compared here with the company's actual past growth.

Growth the price implies (price on 2026-11-04)

10.9%

Perpetual FCF growth: g = r − FCF ÷ EV = 12.7% − 1.8%

Past FCF growth (FY2021–FY2026)

-13.7%

Compound annual rate, 5 years

Past revenue growth (FY2021–FY2026)

-2.8%

Compound annual rate, 5 years

Inputs (FY2026): free cash flow $871M (operating CF − capex); enterprise value $47.73B = market cap $42.48B (latest close, 2026-11-04) + debt $5.5B − cash and short-term investments $240M; r = WACC of 12.7% using this page’s default assumptions (β 1.69, risk-free 5.0%, market premium 5.5%).

Three WACC scenarios

The same calculation under cautious, base and optimistic cost-of-capital assumptions (risk-free rate fixed at the 10-year Treasury yield). Pick one to load it into the sliders below.

Try your own assumptions

V = FCF ÷ (r − g). It starts at the implied growth rate, where the theoretical value equals today’s enterprise value.

Theoretical enterprise value

$48.39B

FCF $871M ÷ (12.7% − 10.9%)

Theoretical ÷ actual enterprise value

1.01x

Above 1x: these assumptions value the business above the market did

How sensitive the answer is

Theoretical ÷ actual enterprise value for each combination of r and g.

g \ r10.7%11.7%12.7%13.7%14.7%
0%0.17x0.16x0.14x0.13x0.12x
2%0.21x0.19x0.17x0.16x0.14x
4%0.27x0.24x0.21x0.19x0.17x
6%0.39x0.32x0.27x0.24x0.21x
8%0.68x0.49x0.39x0.32x0.27x

A simplified model for seeing what the market price assumes, not a forecast or a target price. It treats free cash flow as growing at one constant rate forever; the result swings widely with small changes in r and g, and is undefined when g reaches r. Free cash flow here is operating cash flow minus capex, which is after interest — a full DCF of enterprise value would use cash flow before interest. Market cap uses the latest close (2026-11-04) × shares at fiscal year-end; free cash flow and WACC inputs are from the latest fiscal year.

17

Earnings qualityFrom SEC dataShow

The same reported profit can mean different things depending on whether it's backed by cash, driven by the core business, or the result of a one-off item. Four checks below.

  • ✓

    Operating CF ÷ net income: averages 3.00x

    Profit is backed by cash coming in.

  • ✓

    Accrual ratio (latest): -4.9%

    A small share of profit rests on accounting estimates.

  • ✓

    Core-earnings share (operating income ÷ pretax income): 179%

    Most profit comes from core operations.

  • ✓

    Days sales outstanding: 67 → 61 days

    No major slowdown in collecting on sales.

Operating CF vs. net income

Unit: $M — operating CF above net income means profit is backed by cash

  • Operating CF
  • Net income

formulacash flow from operations ÷ net income attributable to the company

termsCash flow from operations (operating CF) · Net income (attributable to the company)

formula(net income − operating CF) ÷ average total assets × 100

termsNet income (attributable to the company) · Cash flow from operations (operating CF) · Total assets

Source: each period's Form 10-K (SEC EDGAR). Latest: filed 2026-05-21

Profit bridge (FY2026)

Unit: $M — what moved profit from operating income to net income

  • Profit (each stage)
  • Pushed profit up
  • Pushed profit down

formulaoperating income ÷ income before income taxes × 100

termsOperating income · Income before income taxes (pretax income)

Source: each period's Form 10-K (SEC EDGAR). Latest: filed 2026-05-21

Receivables & inventory days

Unit: days — days grow when receivables or inventory build up faster than sales

  • Days sales outstanding
  • Days inventory outstanding

formulaaverage receivables (opening + closing ÷ 2) ÷ revenue × 365

termsAccounts receivable · Revenue (net sales)

formulaaverage inventory (opening + closing ÷ 2) ÷ cost of revenue × 365

termsInventory · Cost of revenue (COGS)

Worked examples (latest period)

formulacash flow from operations ÷ net income attributable to the company

e.g.$962M ÷ $230M = 4.18x

termsCash flow from operations (operating CF) · Net income (attributable to the company)

formulaoperating income ÷ income before income taxes × 100

e.g.$490M ÷ $274M × 100 = 179%

termsOperating income · Income before income taxes (pretax income)

formulaaverage receivables (opening + closing ÷ 2) ÷ revenue × 365

e.g.($690M + $895M) ÷ 2 ÷ $4,713M × 365 = 61 days

termsAccounts receivable · Revenue (net sales)

formulaaverage inventory (opening + closing ÷ 2) ÷ cost of revenue × 365

e.g.($1,294M + $1,035M) ÷ 2 ÷ $1,992M × 365 = 213 days

termsInventory · Cost of revenue (COGS)

18

Who holds the sharesFrom SEC dataShow

How much of the stock large institutional investors report owning on SEC Form 13F, how much the directors and executive officers hold (and how much of the vote they control), and roughly how much is left for individual investors. Shown next to beta so the holder mix can be read alongside how much the stock swings.

Institutions, insiders and everyone else, 13F holdings as of 2026-06-30

“Everyone else” is what remains after shares reported on Form 13F and shares held by directors and executive officers: mostly individual investors, plus non-insider families or foundations and smaller or foreign institutions. The figures have different dates and 13F reports count some shares twice — read it as an approximate split.

Held by 13F filers
100%+

Reported total 100.1%

Directors & officers (shares)
1.8%
Everyone else (est.)
≈0%

individuals and other non-13F holders

Directors & officers (voting power)
1.8%

no separate voting figure; shown as shares

Institutional-ownership rank
60 of 416

1 = most institutional; 14% of covered companies have more

Beta (adjusted)
1.69

above 1 = swings more than the market

  • 543.7M shares reported by 1,285 13F filers ÷ 543.0M shares outstanding on 2026-07-28. Option positions are excluded.
  • The 13F total exceeds shares outstanding because some shares are reported twice — for example shares lent to short sellers and then bought by another manager, or holdings that overlapping managers both report.
  • Directors and executive officers as a group, from the proxy statement’s beneficial-ownership table; includes shares they can acquire within 60 days.
  • A large “everyone else” share can still reflect a family, trust or foundation stake held outside the board; check the proxy statement’s 5% holders.

Sources: SEC Form 13F data set (holdings as of 2026-06-30) · Form DEF 14A filed 2026-07-06 (beneficial ownership table) · Form 10-Q cover page (shares outstanding as of 2026-07-28)

19

Strengths & weaknessesSite analysis

Strengths

  1. 1. Broad, sticky customer base

    Products are designed into long-lived applications across many end markets.

    Evidence: Form 10-K (FY2026, year ended 2026-03-31)

  2. 2. Recovery under way

    Fiscal 2026 net sales rose 7% and operating income to $490M.

    Evidence: Form 10-K (FY2026, year ended 2026-03-31)

  3. 3. Dividend maintained

    Paid about $984M of common dividends in fiscal 2026 despite low earnings.

    Evidence: Form 10-K (FY2026, year ended 2026-03-31)

Weaknesses

  1. 1. Sharp downturn

    Net sales fell 48% from fiscal 2023 to fiscal 2025 during a customer inventory correction.

    Evidence: Form 10-K (FY2026, year ended 2026-03-31)

  2. 2. Weak earnings

    Fiscal 2026 diluted EPS of $0.22 after preferred dividends; dividends far exceed earnings.

    Evidence: Form 10-K (FY2026, year ended 2026-03-31)

  3. 3. Leverage

    Debt of about $5.5B.

    Evidence: Form 10-K (FY2026, year ended 2026-03-31)

20

What draws investors to itSite analysis

Why the stock can look attractive to investors — each point paired with what has to hold for it to stay true, and the opposing view. This is this site's analysis, not a recommendation to buy or sell.

P/E (FY2026)

293.7x

Price at fiscal year-end ÷ diluted EPS

Dividend yield (FY2026)

2.82%

Dividends per share ÷ fiscal year-end price

Payout ratio (FY2026)

414%

Dividends per share ÷ diluted EPS

FCF yield (FY2026)

2.5%

(Operating CF − capex) ÷ market cap

  1. 1. Cyclical upturn

    Sales recovering from the inventory correction.

    What has to hold
    Demand keeps improving.
    The other side
    Uncertain macro.

    Evidence: Form 10-K (FY2026, year ended 2026-03-31)

  2. 2. Dividend income

    Common dividend maintained through the downturn.

    What has to hold
    Earnings recover.
    The other side
    Payout far above earnings.

    Evidence: Form 10-K (FY2026, year ended 2026-03-31)

Fiscal years end March 31. EPS is after preferred dividends.

21

ResilienceSite analysisShow

How well the company could absorb a bad year: its financial buffer, how its revenue and profit held up in the worst year on record, and what the 10-K says about the business's exposure to shocks. Figures and filing statements only — no overall rating.

1. Financial buffer (FY2026)

Cash & short-term investments ÷ debt due within a year

No debt due

$240M vs. $0

Interest coverage (operating income ÷ interest expense)

2.2x

$490M vs. $221M

Free cash flow ÷ dividends paid

0.9x

$871M vs. $984M (FCF = operating CF − capex)

2. Worst year in the record, and the recovery

FigureWorst year-over-year changeBack to the prior level?
Revenue-42.3% in FY2025 ($7.63B → $4.4B)Not yet, as of FY2026
Operating income-88.5% in FY2025 ($2.57B → $296M)Not yet, as of FY2026

Covers only the 6 fiscal years on record (FY2021–FY2026), which may not include a full recession — the worst year here isn’t necessarily how the company would fare in a severe downturn.

3. Business resilience (from the 10-K)

  • Profitable on an operating basis in the downturn

    Operating income stayed positive ($296M) even in fiscal 2025.

    Source: Form 10-K (FY2026, year ended 2026-03-31)

23

Risks (including geopolitical)Site analysis

Starting from the 10-K's Risk Factors section, organized by category — geopolitical, currency, raw materials, regulatory, disaster, and more — with impact and likelihood assessed by this site.

Risk map

Vertical = impact on results, horizontal = likelihood. Upper right = most severe. Numbers match the list below (placement is this site’s own assessment).

Impact
High
1
Med
35
24
Low
LowMedHigh

Likelihood →

"Company disclosure" vs. "this site’s assessment"

The description and mitigation for each risk are this site’s summary of the 10-K’s "Risk Factors" section. Impact and likelihood are this site’s own assessment, not the company’s — where the company discloses its own likelihood assessment, that is noted in the summary.

Impact is judged from how large the affected business is relative to total revenue/profit, and from the risk’s track record of moving results in the past. Likelihood is judged from the filing’s wording and the current business environment (already occurring, or recurring). See the rating criteria.

  1. 1Demand & macro

    Semiconductor inventory cycles

    Company disclosure (summarized from the 10-K)
    Customer inventory corrections can sharply cut orders.
    Company’s stated mitigation
    Not stated in the filings.
    This site’s assessment
    Impact High / Likelihood Med
  2. 2Competition & technology shift

    Competition and cloning

    Company disclosure (summarized from the 10-K)
    Competes with major semiconductor companies; some firms in China and Taiwan copy its products.
    Company’s stated mitigation
    Not stated in the filings.
    This site’s assessment
    Impact Med / Likelihood High
  3. 3Customer/supplier concentration

    Distributor dependence

    Company disclosure (summarized from the 10-K)
    Arrow Electronics accounted for 12% of fiscal 2026 sales.
    Company’s stated mitigation
    Not stated in the filings.
    This site’s assessment
    Impact Med / Likelihood Med
  4. 4Geopolitics & supply chain

    Asia exposure

    Company disclosure (summarized from the 10-K)
    About half of sales are to Asia; trade and export policies matter.
    Company’s stated mitigation
    Not stated in the filings.
    This site’s assessment
    Impact Med / Likelihood High
  5. 5Funding & liquidity

    Debt and dividend commitments

    Company disclosure (summarized from the 10-K)
    Dividends on common and preferred stock plus convertible debt put/repurchase obligations.
    Company’s stated mitigation
    At March 31, 2026, we had no outstanding borrowings under our Revolving Credit Facility, which provides $2.25 billion of revolving loan commitments that terminate in 2030, and $349.0 million outstanding principal amount under our Commercial Paper program.
    This site’s assessment
    Impact Med / Likelihood Med

24

What changed in the risk factorsFrom SEC data

Paragraphs in the latest 10-K's Risk Factors that have little overlap with the year before, and paragraphs that were dropped.

New or substantially reworded (8)

  • Our manufacturing operations require a continuous supply of raw and processed materials, components, and production equipment that must meet stringent performance and quality standards. Read more

    Although we generally maintain multiple sources for these items, only a limited number of suppliers may be capable of meeting our technical requirements. From time to time, we have experienced supply shortages, extended lead times, supplier announcements that certain orders could not be fulfilled, or the discontinuation of updates or parts for certain equipment. For example, in fiscal 2023 and fiscal 2022, we experienced cost increases from certain suppliers for materials used in our production processes; although conditions stabilized in fiscal 2024 and fiscal 2025, similar cost pressures may recur.

  • Any interruption in the supply of raw materials, components, or equipment - or reduced supplier support for key manufacturing tools - could adversely affect our ability to produce products in the required volumes or on expected timelines. Read more

    Supply availability may be further limited as global semiconductor demand increases, suppliers shift production toward higher cost or more complex products, or as a result of supply chain disruptions, transit delays, or political instability. For example, as memory manufacturers transition to more advanced products, availability of the memory components we use may become constrained, have longer lead times, or become more expensive. Consolidation among suppliers may reduce supply alternatives or alter our commercial relationships. In addition, reduced labor availability or public health concerns may further impact the supply chain.

  • Any of these factors could increase our manufacturing costs, impair our sourcing flexibility, delay our production schedules, and adversely affect our operating results. Read more

    Additionally, our sales may be adversely impacted if tariffs or government trade actions restrict access to needed supplies.

  • Tariffs, trade restrictions, and evolving global trade policies pose risks to our supply chain, cost structure, and customer demand. Read more

    Beginning in 2018 and continuing through 2026, the U.S. imposed additional tariffs on various imports, and several countries have imposed retaliatory tariffs on goods originating from the U.S. Although semiconductors currently remain exempt from certain U.S. tariffs under the ongoing Section 232 investigation, many inputs used in semiconductor manufacturing - including chemicals, metals, and equipment - remain subject to country specific tariffs or may become subject to new duties. The tariff landscape remains uncertain and may change with limited notice.

  • New or increased tariffs imposed on raw materials, components, equipment, or other inputs used in our production processes could increase our manufacturing costs. Read more

    We may also incur incremental costs associated with supply chain adjustments undertaken to mitigate the effects of trade restrictions or tariffs. While we attempt to reduce cost burdens and secure alternative supply arrangements, we may experience higher operating costs, reduced sourcing flexibility, or lower demand for our products if customers face higher input costs or trade related disruptions.

  • Tariffs and trade restrictions also affect our customers. If customers face reduced availability of labor, materials, or components, whether due to trade restrictions, supplier disruptions, escalating shipping constraints, or public health issues, they may reduce or suspend production of their own products, leading to decreased demand for our products. For example, in 2025, government actions involving Nexperia (including export control measures and interventions affecting its operations and cross-border shipments) resulted in restricted availability of certain mature-node semiconductors (such as discrete devices and standard logic) that are widely used by automotive and consumer electronics manufacturers. As a result, some of our customers may experience shortages of these components which may reduce their production volumes and, in turn, reduce demand for our products. Any such…

  • On February 20, 2026, the U.S. Supreme Court ruled that certain tariffs collected pursuant to the International Emergency Economic Powers Act (IEEPA) were unconstitutional. Read more

    On April 20, 2026, the U.S. Customs and Border Protection (CBP) began processing refunds through its Consolidated Administration and Processing of Entries (CAPE) portal. Although Microchip was the importer of record for products that were subject to tariffs imposed under IEEPA and should be entitled to a refund, the timing and the amount of any such recovery is not yet clear. As such, this could have a favorable impact on our financial position, operations, or cash flows, but we cannot predict the timing, likelihood, or amount of any refunds or other recoveries we may realize.

  • We may lose sales if critical materials from concentrated sources become restricted or subject to export controls.

No longer in the text (4)

  • We may lose sales if suppliers of raw materials, components or equipment fail to meet our or our customers' needs, increase prices, are impacted by increases in tariffs, or such raw materials, components or equipment become restricted or unavailable.

  • Our manufacturing operations require raw and processed materials and equipment that must meet exacting standards. Read more

    We generally have multiple sources for these supplies, but there may be a limited number of suppliers capable of meeting our standards. We have experienced supply shortages from time to time in the past, and on occasion our suppliers have told us they need more time to fill our orders, that they cannot fill certain orders, that they will no longer support certain equipment with updates or parts, or that they are increasing prices. In particular, in fiscal 2023 and in fiscal 2022, we experienced increased prices at certain suppliers for certain materials required for production purposes. However, in fiscal 2024 and fiscal 2025, the pricing environment stabilized compared to the two prior fiscal years. An interruption of any materials or equipment sources, or the lack of…

  • Additional tariffs imposed on components, raw materials, or equipment may increase our costs and have an adverse impact on our operating results in future periods. Read more

    We may also incur increases in manufacturing costs in mitigating the impact of tariffs on our operations. We will attempt to mitigate the impact of those tariffs on our business but may experience an increase in operating costs, impaired sourcing flexibility, and reduced demand for our products, resulting in reduced revenue.

  • Our customers may also be adversely affected by the tariffs and other issues described above. Read more

    The labor, supplies and equipment necessary for their businesses could become more difficult to obtain for various reasons not limited to business interruptions of suppliers, reduced availability of labor, transit disruptions, consolidation in their supply chain, or sanctions, trade restrictions or tariffs or the impact of public health concerns that impair sourcing flexibility or increase costs. If our customers are not able to produce their products, then their need for our products will decrease. Such interruptions of our customers’ businesses could harm our business.

23 more paragraphs differ; the filings below have the full text.

Matched automatically, quoted as filed, and may include rewording of an existing risk. Compares Item 1A of the 10-K filed May 21, 2026 ↗ with the 10-K filed May 23, 2025 ↗.

25

What to watch going forwardSite analysis

  • Order recovery and inventory normalization.
  • Gross margin as fab utilization improves.
  • Dividend coverage.
  • Convertible debt repurchase rights in June 2027.

26

Source documentsShow

This page's financial figures come from the Form 10-Ks listed below. Check the original filings for full detail.

Last updated

Analysis last edited: November 6, 2026 · Financial data fetched: October 29, 2026 13:24 (SEC EDGAR) · Source 10-K filed: May 21, 2026

Built on10-K FY2026 · filed 2026-05-21Proxy statement (2026)

Next update expectedAfter FY2027’s 10-K is filed (roughly 60–90 days after fiscal year end (sooner for larger filers)), financials and analysis will be refreshed.

This page is this site’s own analysis based on public information, and does not represent Microchip Technology’s views. It is not a recommendation to buy or sell any security, and this site does not guarantee the accuracy of any figure or statement here. Always verify against the original source documents before making an investment decision.